E-LIB Suche - Ergebnisse für: Hattersley, Maureen M

1

A phase 2 study of AZD4635 in combination with durvalumab o..:

Falchook, Gerald S. ; Reeves, James ; Gandhi, Sunil...
Cancer Immunology, Immunotherapy. 73 (2024) 4 - p. , 2024

Link: https://doi.org/10.1007/..

2

First-in-human Study of AZD5153, A Small-molecule Inhibitor..:

Hamilton, Erika P. ; Wang, Judy S. ; Oza, Amit M....
Molecular Cancer Therapeutics. 22 (2023) 10 - p. 1154-1165 , 2023

Link: https://doi.org/10.1158/..

3

BET inhibition targets ABC-DLBCL constitutive B-cell recept..:

Oien, Derek B. ; Sharma, Samanta ; Hattersley, Maureen M....
Blood Advances. 7 (2023) 17 - p. 5108-5121 , 2023

Link: https://doi.org/10.1182/..

4

The landscape of therapeutic vulnerabilities in EGFR inhibi..:

Criscione, Steven W. ; Martin, Matthew J. ; Oien, Derek B....
npj Precision Oncology. 6 (2022) 1 - p. , 2022

Link: https://doi.org/10.1038/..

5

Phase Ia/b, Open-Label, Multicenter Study of AZD4635 (an Ad..:

Lim, Emerson A. ; Bendell, Johanna C. ; Falchook, Gerald S....
Clinical Cancer Research. 28 (2022) 22 - p. 4871-4884 , 2022

Link: https://doi.org/10.1158/..

6

VEGF pathway inhibition potentiates PARP inhibitor efficacy..:

Bizzaro, Francesca ; Fuso Nerini, Ilaria ; Taylor, Molly A....
Journal of Hematology & Oncology. 14 (2021) 1 - p. , 2021

Link: https://doi.org/10.1186/..

7

Bromodomain and extra-terminal inhibitors—A consensus prior..:

Pearson, Andrew DJ. ; DuBois, Steven G. ; Buenger, Vickie...
European Journal of Cancer. 146 (2021) - p. 115-124 , 2021

Link: https://doi.org/10.1016/..

8

Heteroarylamide smoothened inhibitors: Discovery of N-[2,4-..:

Yang, Bin ; Hird, Alexander W. ; Bodnarchuk, Michael S....
Bioorganic & Medicinal Chemistry. 28 (2020) 2 - p. 115227 , 2020

Link: https://doi.org/10.1016/..

9

BRD4 amplification facilitates an oncogenic gene expression..:

Rhyasen, Garrett W. ; Yao, Yi ; Zhang, Jingwen...
PLOS ONE. 13 (2018) 7 - p. e0200826 , 2018

Link: https://doi.org/10.1371/..

10

BRD4 facilitates replication stress-induced DNA damage resp..:

Zhang, Jingwen ; Dulak, Austin M. ; Hattersley, Maureen M....
Oncogene. 37 (2018) 28 - p. 3763-3777 , 2018

Link: https://doi.org/10.1038/..

11

3-Amido-4-anilinoquinolines as CSF-1R kinase inhibitors 2: ..:

Scott, David A. ; Bell, Kirsten J. ; Campbell, Cheryl T....
Bioorganic & Medicinal Chemistry Letters. 19 (2009) 3 - p. 701-705 , 2009

Link: https://doi.org/10.1016/..

12

Pyridyl and thiazolyl bisamide CSF-1R inhibitors for the tr..:

Scott, David A. ; Aquila, Brian M. ; Bebernitz, Geraldine A....
Bioorganic & Medicinal Chemistry Letters. 18 (2008) 17 - p. 4794-4797 , 2008

Link: https://doi.org/10.1016/..

13

BET inhibition targets ABC-DLBCL constitutive B-cell recept..:

Oien, Derek B ; Sharma, Samanta ; Hattersley, Maureen M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477446/. , 2023

Link: http://www.ncbi.nlm.nih...

14

First-in-human Study of AZD5153, A Small-molecule Inhibitor..:

Hamilton, Erika P ; Wang, Judy S ; Oza, Amit M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544002/. , 2023

Link: http://www.ncbi.nlm.nih...

15

The landscape of therapeutic vulnerabilities in EGFR inhibi..:

Criscione, Steven W ; Martin, Matthew J ; Oien, Derek B...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794691/. , 2022

Link: http://www.ncbi.nlm.nih...